AbbVie Biotech Innovators Award
In collaboration with the University of Toronto’s SpinUp incubator, AbbVie’s Biotech Innovators Award provides one early-stage Canadian biotech with a year of subsidized wet-lab space, core equipment access, entrepreneurship programming, and AbbVie mentorship to accelerate transformational therapies in immunology, oncology, neuroscience, or eye care.
Eligibility Criteria:
-
Early-stage Canadian biotechnology startups with therapeutic projects in AbbVie’s focus areas.
-
Companies must propose laboratory-based R&D projects (wet-lab chemistry or biology).
-
Demonstrated scientific innovation and potential for transformational impact.
-
Not open to established pharma; designed for startups at proof-of-concept/preclinical stage.
Funding Details:
-
Lab Space & Equipment: 1 year at SpinUp’s state-of-the-art U of T Mississauga facility, at no cost.
-
Entrepreneurial Support: Access to SpinUp’s entrepreneurship programming and research community.
-
Mentorship: Scientific and business guidance from AbbVie executives.
Where to Go for Further Information:
Apply or download guidelines at SpinUp’s Biotech Innovators Award page.
For questions, email AbbVie Canada: [email protected].
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023